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Since  the  desoxycorticosterone-mimetic  action  of  glycyrrhizin  has  been 
reported, clinicians have been interested in its pharmacodynamics and possible 
therapeutic  value.  The  minerosteroid-like  activity  of  crude  licorice  extract 
was first observed in normal individuals  (1,  2).  Subsequently,  both the active 
principle,  glycyrrhizinic  acid  (3)  and  the  crude  extract  have  been  shown 
capable  of replacing  desoxycorficosterone in  treatment  of patients  with  Ad- 
dison's  disease  (3-8)  or  with  total  adrenalectomy  (9).  Glycyrrhizin-induced 
retention  of  sodium  and  water  has  been  demonstrated  in  both  intact  (10) 
and adrenalectomized  (10,  11) rats. 
The  action  of  glycyrrhizin further  resembles  that  of  desoxycorticosterone 
in  its  inhibitory  effect  on  the  pituitary-adrenal  system  (10,  12).  Animals 
treated  with  glycyrrhizin  develop  adrenal  cortical  atrophy  (12)  and  show 
less  than  normal  reduction  of adrenal  ascorbic  acid  in  response  to  histamine 
(10).  In the  present  investigation  two additional  indices  of pituitary-adrenal 
function,  namely  resistance  to  cold  stress  and  capacity  to  mobilize  glucose 
during fasting,  were studied in normal and glycyrrhizin-treated animals. 
Methods 
Resistance of Mice to Prolonged Cold Stress.--The survival rate as a measure of resistance 
to prolonged stress was determined  in glycyrrhizin-treated  and untreated mice. Male mice, 
8 to 10 gin., (10 untreated  and 10 treated)  were individually housed, and exposed for 8 hours 
to a  temperature  of 5°C. Glycyrrhizin-treated  mice had received 0.4 per cent ammoniated 
glycyrrhizin in place of drinking water for 4 days prior to stress. 
Glucose Mobilization  of Rats Subjected tO 48 Hours of Fasting.--Fasting  of rats causes an 
initial  hypoglycemia followed by a pituitary-adrenal  response with  mobilization of glucose 
(13). The concentration of glucose in blood after 48 hours of fasting was observed in 5 treated 
and 5 untreated male rats (145 to 150 gm.), the glycyrrhlzin-treated  rats having received 0.4 
per cent ammoniated  glycyrrhizin in place of drinking water for 1 week prior to the test. 
* Ammoniated glycyrrhizin granules supplied by S. B. Penick and Co., New York. 
:~ Aided by the National  Institutes of Health,  Research Grant H2852. 
§ An abstract of this work appeared in Fed. Proc., March,  1957, 16, 314. 
Present  address: Long Island  University,  Brooklyn College of Pharmacy, Brooklyn. 
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Blood glucose levels were determined on tail vein blood at 0, 24, and 48 hours. The capacity 
to mobilize glucose was judged from the relative values at 24 and 48 hours. 
RESULTS 
Resistance  to  Prolonged Cold Slress.--Glycyrrhizin-treated  mice  died  more 
rapidly than  untreated  mice during  exposure  to cold stress for 8 hours  (Fig. 
1). The  median  survival  times for untreated  and  treated  mice were 6.5  and 
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FIo. 1. Survival rate of glycyrrhizin-pretreated male mice (intact) 8 to 10 gm., subjected 
to  cold stress (5°C.)  compared with untreated controls. Experimental animals received am- 
moniated glycyrrhizin (0.4  per cent)  ad t//dt~ra  for a  period of 4  days prior to stress. Ten 
animals in each group, individually housed  and  stressed for 8 hours. Median survival times: 
controls 5.5 4- 0.5 hours; experimental 2.6 4- 0.6 hours (50 per cent less than controls P  < 
O.OOi). 
2.6  hours  respectively  (Fig.  1).  The  resistance  of mice  treated  with  glycyr- 
rhizin  was 60 per cent less (P  <  0.001)  than  that  of the untreated  controls 
(Fig. i). 
Glucose Mobilization  after 44  Hours  of  Fasting.--Glycyrrhizin  decreased 
the ability of rats to mobilize glucose (Fig.  2). Mter 24 hours of fasting both 
groups  exhibited  the  expected  degree  of  hypoglycemia  (Fig.  2).  After  48 
hours, untreated  rats had mobilized sufficient glucose to bring  the blood glu- 
cose level up to a value which was not significantly different from the control 
(Fig.  2).  In contrast,  the 48 hour  blood glucose of glycyrrhizin-treated  rats 
was significantly (P  <  0.01) depressed. SmRLV:Z D. tCgAUS  327 
DISCUSSION 
Cold  and  fasting  presumably  increase  adrenocortical  activity  through 
release  of  ACTH,  1  the  degree  of  adrenocortical  activity  depending  upon 
the  quantity  of hormone released  from the  pituitary  and  the  responsiveness 
of the adrenal  cortex (14). In the present study, the normal animals responded 
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FIo. 2. Glucose mobilization response of glycyrrhizin treated and untreated intact male 
rats  subjected  to 48  hours  of fasting  stress. Experimental  animals  received  ammoniated 
glycyrrhizin  (0.4 per cent)  ad libitum for 1 week prior to stress. 5 animals in each group. 
Blood glucose determined  on tail  vein blood at 0, 24, and 48 hours of fasting.  Analysis of 
variance  :-- 
I. 24 hours of fasting  (hypoglycemia): (a) difference  from control;  untreated P  0.01, 
treated P  <  0.01. (b) difference between groups; not significant. 
2. 48 hours of fasting  (glucose mobilization):  (a)  difference from control;  untreated not 
significant, treated  P  <  0.01; (b) difference between groups;  treated  22.8 per cent of  the 
response of untreated  (P 0.05). 
to these stresses with increased production of corticoid, as evidenced by their 
resistance  to  the  stresses  and  by  the  mobilization  of glucose.  Those  treated 
with  glycyrrhizin  had  a  higher  mortality  and  a  diminished  mobilization  of 
glucose.  These  observations,  coupled  with  the  decrease  in  adrenal  ascorbic 
acid  response  (10)  and  the  atrophy  of  the  adrenal  cortex  (12)  observed  in 
glycyrrhizin-treated  animals,  strongly  suggest  that  glycyrrhizin  depresses 
the output of ACTH. 
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Desoxycorticosterone  exerts  a  similar  inhibitory  effect  on  the  pituitary- 
adrenal  system  through  depression  of ACTH  release  (15).  Like  glycyrrhizin 
it causes adrenal  cortical  atrophy  (15,  16),  diminished  adrenal  ascorbic acid 
response  (15),  diminished  glucose mobilization  and  impaired  resistance  (16). 
Although  the  mechanism  of  action  of  glycyrrhizin  is  as  yet  unknown,  its 
actions  strongly  resemble  desoxycorticosterone  in  both  its  effect  on  the 
pituitary-adrenal  system as well as its effect on electrolyte metabolism (1-11). 
SUMMARY 
Glycyrrhizin decreased the resistance of intact male mice to prolonged 
exposure to cold  (8 hours at 5°C.)  and it decreased the ability  of intact  male 
rats  to mobilize glucose when subjected to 48 hours of fasting.  It is suggested 
that glycyrrhizin,  like  desoxycorticosterone,  depresses  the output of ACTH. 
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